First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder
First in Man Study to Evaluate Safety and Efficacy of Left Atrial Appendage Pulsed Field Ablation Occluder for Simultaneous Pulsed Field Ablation and Mechanical Closure of the Left Atrial Appendage in Patients With Nonvalvular Atrial Fibrillation
Sponsor: Hangzhou Dinova EP Technology Co., Ltd
A NA clinical study on Nonvalvular Atrial Fibrillation, this trial is ongoing. The trial is conducted by Hangzhou Dinova EP Technology Co., Ltd and has accumulated 6 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Feb 2026 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Feb 2024 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2023 — Feb 2024 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Mar 2023 — Jun 2023 [monthly]
Recruiting NA
First recorded
Jul 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hangzhou Dinova EP Technology Co., Ltd
For direct contact, visit the study record on ClinicalTrials.gov .